[J-CATIA研究(日本阿尔茨海默病抗精神病药物治疗联盟)建议]。

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica Pub Date : 2016-01-01

Heii Arai

{"title":"[J-CATIA研究(日本阿尔茨海默病抗精神病药物治疗联盟)建议]。","authors":"Heii Arai","doi":"","DOIUrl":null,"url":null,"abstract":"The mortality risk of long-term and new antipsychotic drug use in Alzheimer's disease (AD) patients in Japan was studied to determine improved treatment protocols. One of the main findings was that newly prescribed users showed increased mortality. Therefore, the new use of antipsychotic drugs represents a distinct mortality risk, while those on long-term anti- psychotic therapy are suggested to be relatively safe.","PeriodicalId":21638,"journal":{"name":"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica","volume":"118 11","pages":"845-848"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Suggestions Obtained from the J-CATIA Study (Japan Consortium for Antipsychotics Treatment in Alzheimer's Disease)].\",\"authors\":\"Heii Arai\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The mortality risk of long-term and new antipsychotic drug use in Alzheimer's disease (AD) patients in Japan was studied to determine improved treatment protocols. One of the main findings was that newly prescribed users showed increased mortality. Therefore, the new use of antipsychotic drugs represents a distinct mortality risk, while those on long-term anti- psychotic therapy are suggested to be relatively safe.\",\"PeriodicalId\":21638,\"journal\":{\"name\":\"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica\",\"volume\":\"118 11\",\"pages\":\"845-848\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

研究了日本阿尔茨海默病(AD)患者长期和新型抗精神病药物使用的死亡风险，以确定改进的治疗方案。其中一个主要发现是，新开处方的服用者死亡率增加。因此，抗精神病药物的新使用代表着明显的死亡风险，而长期抗精神病药物治疗被认为是相对安全的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Suggestions Obtained from the J-CATIA Study (Japan Consortium for Antipsychotics Treatment in Alzheimer's Disease)].

The mortality risk of long-term and new antipsychotic drug use in Alzheimer's disease (AD) patients in Japan was studied to determine improved treatment protocols. One of the main findings was that newly prescribed users showed increased mortality. Therefore, the new use of antipsychotic drugs represents a distinct mortality risk, while those on long-term anti- psychotic therapy are suggested to be relatively safe.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica

自引率

0.00%

发文量